دورية أكاديمية

Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations.

التفاصيل البيبلوغرافية
العنوان: Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations.
المؤلفون: Zipitis CS; Jenny Lind Children's Department, Norfolk and Norwich University Hospital, Colney Lane, Norwich, NR4 7UY, UK. czipitis@hotmail.com, Thalange N
المصدر: European journal of pediatrics [Eur J Pediatr] 2007 Jun; Vol. 166 (6), pp. 585-8. Date of Electronic Publication: 2006 Sep 29.
نوع المنشور: Case Reports; Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7603873 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0340-6199 (Print) Linking ISSN: 03406199 NLM ISO Abbreviation: Eur J Pediatr Subsets: MEDLINE
أسماء مطبوعة: Publication: Berlin : Springer Verlag
Original Publication: Berlin, New York, Springer-Verlag.
مواضيع طبية MeSH: Immunoglobulins, Intravenous/*therapeutic use , Mycoplasma pneumoniae/*pathogenicity , Stevens-Johnson Syndrome/*drug therapy, Adolescent ; Diagnosis, Differential ; Humans ; Male ; Mycoplasma pneumoniae/isolation & purification ; Stevens-Johnson Syndrome/diagnosis ; Stevens-Johnson Syndrome/physiopathology
مستخلص: Here we describe the successful use of intravenous immunoglobulin (IVIG) in the management of mycoplasma-induced, atypical Stevens-Johnson syndrome (SJS) with minimal skin manifestations. The patient was successfully managed with high-dose IVIG 0.5 g/kg for 4 consecutive days. No complications were noted. IVIG may be useful in the management of mycoplasma-induced SJS.
References: Ann Surg. 1986 Nov;204(5):503-12. (PMID: 3767483)
Pediatrics. 2003 Dec;112(6 Pt 1):1430-6. (PMID: 14654625)
J Am Acad Dermatol. 2002 Oct;47(4):548-52. (PMID: 12271299)
Clin Pediatr (Phila). 1991 Jan;30(1):42-9. (PMID: 1899814)
Ann Allergy. 1994 Jul;73(1):27-34. (PMID: 8030799)
Science. 1998 Oct 16;282(5388):490-3. (PMID: 9774279)
Arch Dermatol. 1987 Sep;123(9):1160-5. (PMID: 3632000)
Pediatr Dermatol. 2003 Jan-Feb;20(1):52-6. (PMID: 12558848)
N Engl J Med. 2001 Sep 6;345(10):747-55. (PMID: 11547745)
Pediatr Dermatol. 2005 Jul-Aug;22(4):317-20. (PMID: 16060867)
Acta Derm Venereol. 1991;71(2):171-2. (PMID: 1675532)
Arch Dermatol. 1993 Jan;129(1):92-6. (PMID: 8420497)
Arch Dermatol. 1990 Jan;126(1):43-7. (PMID: 2404462)
J Am Acad Dermatol. 2005 Feb;52(2):312-5. (PMID: 15692479)
Arch Pediatr. 2004 Aug;11(8):972-3. (PMID: 15288092)
Arch Dermatol. 2003 Jan;139(1):33-6. (PMID: 12533161)
Clin Exp Dermatol. 2005 Sep;30(5):600-2. (PMID: 16045716)
Arch Dermatol. 2003 Jan;139(1):39-43. (PMID: 12533162)
Burns. 1995 Mar;21(2):130-5. (PMID: 7766322)
Pediatr Med Chir. 1992 Sep-Oct;14(5):555-6. (PMID: 1488317)
J Rheumatol. 2000 Oct;27(10):2494-7. (PMID: 11036849)
J Am Acad Dermatol. 1985 Jan;12 (1 Pt 2):178-81. (PMID: 3973116)
Dermatol Clin. 1992 Jul;10(3):571-82. (PMID: 1617814)
Arch Dis Child. 2000 Oct;83(4):347-52. (PMID: 10999875)
Arch Dermatol. 2003 Jan;139(1):26-32. (PMID: 12533160)
N Engl J Med. 1994 Nov 10;331(19):1272-85. (PMID: 7794310)
المشرفين على المادة: 0 (Immunoglobulins, Intravenous)
تواريخ الأحداث: Date Created: 20060930 Date Completed: 20070920 Latest Revision: 20181113
رمز التحديث: 20240628
DOI: 10.1007/s00431-006-0287-9
PMID: 17008995
قاعدة البيانات: MEDLINE
الوصف
تدمد:0340-6199
DOI:10.1007/s00431-006-0287-9